- Home
- IMNN vs SCNX Comparison
IMNN vs SCNX Comparison
Compare IMNN & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNN
- SCNX
- Stock Information
- Founded
- IMNN 1982
- SCNX 2010
- Country
- IMNN United States
- SCNX United States
- Employees
- IMNN N/A
- SCNX N/A
- Industry
- IMNN Biotechnology: Pharmaceutical Preparations
- SCNX Other Pharmaceuticals
- Sector
- IMNN Health Care
- SCNX Health Care
- Exchange
- IMNN Nasdaq
- SCNX Nasdaq
- Market Cap
- IMNN 12.1M
- SCNX 14.4M
- IPO Year
- IMNN 1985
- SCNX 2020
- Fundamental
- Price
- IMNN $0.80
- SCNX $1.45
- Analyst Decision
- IMNN Buy
- SCNX
- Analyst Count
- IMNN 2
- SCNX 0
- Target Price
- IMNN $14.00
- SCNX N/A
- AVG Volume (30 Days)
- IMNN 2.3M
- SCNX 161.5K
- Earning Date
- IMNN 08-13-2025
- SCNX 08-10-2025
- Dividend Yield
- IMNN N/A
- SCNX N/A
- EPS Growth
- IMNN N/A
- SCNX N/A
- EPS
- IMNN N/A
- SCNX N/A
- Revenue
- IMNN N/A
- SCNX $146,901.00
- Revenue This Year
- IMNN N/A
- SCNX N/A
- Revenue Next Year
- IMNN N/A
- SCNX N/A
- P/E Ratio
- IMNN N/A
- SCNX N/A
- Revenue Growth
- IMNN N/A
- SCNX N/A
- 52 Week Low
- IMNN $0.37
- SCNX $0.69
- 52 Week High
- IMNN $3.65
- SCNX $23.77
- Technical
- Relative Strength Index (RSI)
- IMNN 41.12
- SCNX N/A
- Support Level
- IMNN $0.70
- SCNX N/A
- Resistance Level
- IMNN $0.82
- SCNX N/A
- Average True Range (ATR)
- IMNN 0.10
- SCNX 0.00
- MACD
- IMNN -0.05
- SCNX 0.00
- Stochastic Oscillator
- IMNN 11.49
- SCNX 0.00
About IMNN Imunon Inc.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).
About SCNX Scienture Holdings Inc. Common Stock
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.